semaglutide asa guidelines New therapeutic agents for type 2 diabetes: anaesthetic considerations. A narrative review Patients taking the new class

Most weight loss injections require gradual dose increases to improve tolerability

Phase 2 trial results on the efficacy of retatrutide for obesity treatment were presented at the 2023 Scientific Sessions

Reducing caffeine intake or spreading it out over the day can help avoid mood-related side effects

We strive to change your life and help you become the best version of you that you're looking to be

A 2023 review published in Contraception examined GLP-1 receptor agonist use alongside hormonal contraception and concluded that while pharmacokinetic changes are real, evidence of actual contraceptive failure in clinical use is limited